Andrew Leake, MD
Vascular Surgery · Richmond, VANPI 1730405127
Payments from drug & device makers
What this record shows
This record is dominated by other: $13,833 of the $17,183 with a category attached, or 80.5%. Angiodynamics, Inc. accounts for 80.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $8,109 and has fallen 91.5% since, to $691 in 2025.
Across 62 payments — averaging $277.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$14K
- Medtronic$1K
- Philips North America LLC$623
- Penumbra, Inc.$486
- W. L. Gore & Associates, Inc.$313
- Silk Road Medical, Inc.$267
- plus $527 from 7 others
What the payments were for
- Food & beverage$3,34919%
- Other$13,83381%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 7 | $13,863 |
| Medtronic(2 entities) | 21 | $1,104 |
| Philips North America LLC | 9 | $623 |
| Penumbra, Inc. | 6 | $486 |
| W. L. Gore & Associates, Inc. | 3 | $313 |
| Silk Road Medical, Inc. | 4 | $267 |
| Cook Medical LLC | 3 | $252 |
| Abbott | 1 | $91 |
| Bard Peripheral Vascular, Inc. | 1 | $64 |
| Johnson & Johnson | 4 | $56 |
| Baxter Healthcare | 1 | $28 |
| Lemaitre Vascular, Inc. | 1 | $22 |
| BD | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$13,833
- ENDURANT IIS$318
- Indigo$209
- Indigo System$170
- GORE TAG Thoracic Endoprosthesis$167
- VenaSeal$150
- (5028) IGT Devices Systems Undivided$149
- IV Other$149
- Valiant Navion$144
- Abre$137
- EXCLUDER AAA Endoprosthesis$130
- ENROUTE Transcarotid Neuroprotection System$127
- ENROUTE Transcarotid Stent$127
- Cook Medical Thoracic$125
- Cook Medical AFEN$111
- (4066) Tack Endo Sys ATK$109
- IntraSight 2 Mobile$104
How this compares
$17,183 in reported general payments places this provider in the 70th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 36 | $25,533 |
| XareltoRivaroxaban | 11 | $12,294 |
| ClopidogrelClopidogrel Bisulfate | 46 | $774 |
| Gabapentin | 24 | $362 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 53 | $355 |
| Cilostazol | 16 | $281 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $183 |
| Tramadol Hcl | 33 | $62 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $56 | $12,29411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 143 vascular surgery providers in Virginia.
Other vascular surgery in Richmond
- John DeitrickRichmond$684K
- Daniel NewtonRichmond$25K
- Michael AmendolaRichmond$18K
- Mark LevyRichmond$17K
- Michael MarcinczykRichmond$10K
- Jean PannetonVirginia Beach$1.3M
- Rasesh ShahChesapeake$465K
- David DexterNorfolk$404K
- Samuel SteermanVirginia Beach$252K
- Joseph BabrowiczFairfax$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.